Text of What a $242K Performance Audit Says About Electing a New Chair of California's Stem Cell Agency

Replacement of the chair and vice-chair of the California stem cell agency was addressed last fall in the triennial performance audit commissioned by the agency itself. Below is the full text of what the $242,000 study had to say on the matter along with the response from the California Institute for Regenerative Medicine (CIRM), as the agency is offici…